PuigdellÃvol-Sánchez, A.; Juanes-González, M.; Calderón-Valdiviezo, A.; Valls-Foix, R.; González-Salvador, M.; Lozano-Paz, C.; Vidal-Alaball, J.
COVID-19 in Relation to Polypharmacy and Immunization (2020–2024). Viruses 2024, 16, 1533.
https://doi.org/10.3390/v16101533
AMA Style
PuigdellÃvol-Sánchez A, Juanes-González M, Calderón-Valdiviezo A, Valls-Foix R, González-Salvador M, Lozano-Paz C, Vidal-Alaball J.
COVID-19 in Relation to Polypharmacy and Immunization (2020–2024). Viruses. 2024; 16(10):1533.
https://doi.org/10.3390/v16101533
Chicago/Turabian Style
PuigdellÃvol-Sánchez, Anna, Marta Juanes-González, Ana Calderón-Valdiviezo, Roger Valls-Foix, Marta González-Salvador, Celia Lozano-Paz, and Josep Vidal-Alaball.
2024. "COVID-19 in Relation to Polypharmacy and Immunization (2020–2024)" Viruses 16, no. 10: 1533.
https://doi.org/10.3390/v16101533
APA Style
PuigdellÃvol-Sánchez, A., Juanes-González, M., Calderón-Valdiviezo, A., Valls-Foix, R., González-Salvador, M., Lozano-Paz, C., & Vidal-Alaball, J.
(2024). COVID-19 in Relation to Polypharmacy and Immunization (2020–2024). Viruses, 16(10), 1533.
https://doi.org/10.3390/v16101533